The SOUL cardiovascular outcomes trial (n=9,650) demonstrated a 14% relative risk reduction in major adverse cardiovascular events with oral semaglutide 14 mg versus placebo over approximately 4 years
15 :e1700557 Corresponding author: izzahfadilah
Xiang, S., Gu, H., Jin, L., Thorne, R
Watch for: Significantly decreased urine output Dark-colored urine that does not improve with hydration Swelling in the ankles or feet Persistent fatigue with decreased urination Semaglutide side effects compared to other GLP-1 medications If you are considering semaglutide versus tirzepatide or evaluating other options, understanding how side effect profiles compare helps inform decision-making
Let me demonstrate with the 10,000 mcg/mL concentration from adding 2mL water to a 20mg vial
Juice often removes this fiber and can lead to a quicker spike in blood sugar, so moderation is key